Blunted opiate modulation of hypothalamic-pituitary-adrenocortical activity in men and women who smoke

Psychosomatic Medicine

Volumn 70, Issue 8, 2008, Pages 928-935

  Al'Absi, Mustafa ^a   Wittmers, Lorentz E ^a   Hatsukami, Dorothy ^a   Westra, Ruth ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

Adrenocorticotropin; Cortisol; Endogenous opioids; Naltrexone; Pain; Smoking; Stress

Indexed keywords

CORTICOTROPIN; HYDROCORTISONE; NALTREXONE; OPIATE DERIVATIVE; PLACEBO; NARCOTIC ANTAGONIST; NICOTINE; OPIATE PEPTIDE;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COLD PRESSOR TEST; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORTICOTROPIN BLOOD LEVEL; DOUBLE BLIND PROCEDURE; FEMALE; HEAT TOLERANCE; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MALE; MENTAL STRESS; MOOD; NOCICEPTIVE STIMULATION; PAIN; PAIN THRESHOLD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REWARD; SEX DIFFERENCE; SINGLE BLIND PROCEDURE; SMOKING; TOBACCO DEPENDENCE; AROUSAL; BLOOD; CHEMISTRY; DRUG EFFECT; HYPOPHYSIS ADRENAL SYSTEM; HYPOTHALAMUS HYPOPHYSIS SYSTEM; PAIN ASSESSMENT; PATHOPHYSIOLOGY; PHYSIOLOGY; SALIVA; TEMPERATURE SENSE;

ADRENOCORTICOTROPIC HORMONE; AROUSAL; DOUBLE-BLIND METHOD; FEMALE; HUMANS; HYDROCORTISONE; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; MALE; NALTREXONE; NARCOTIC ANTAGONISTS; NICOTINE; OPIOID PEPTIDES; PAIN MEASUREMENT; PAIN THRESHOLD; PITUITARY-ADRENAL SYSTEM; SALIVA; SEX FACTORS; TEMPERATURE SENSE; TOBACCO USE DISORDER; YOUNG ADULT;

EID: 60849136952     PISSN: 00333174     EISSN: 15347796     Source Type: Journal    
DOI: 10.1097/PSY.0b013e31818434ab     Document Type: Article

References (57)

1. Buckingham JC, Cooper TA. Interrelationships of opioidergic and adren-ergic mechanisms controlling the secretion of corticotrophin releasing factor in the rat. Neuroendocrinology 1987;46:199-206.
2. Buckingham JC. Stimulation and inhibition of corticotrophin releasing factor secretion by beta endorphin. Neuroendocrinology 1986;42:148-152
3. Feek CM, Marante DJ, Edwards CR. The hypothalamic-pituitary-adrenal axis. Clin Endocrinol Metab 1983;12:597-618.
4. Kirschbaum C, Strasburger CJ, Langkrar J. Attenuated cortisol response to psychological stress but not to CRH or ergometry in young habitual smokers. Pharmacol Biochem Behav 1993;44:527-531
5. al'Absi M, Wittmers LE, Erickson J, Hatsukami DK, Crouse B. Attenuated adrenocortical and blood pressure responses to psychological stress in ad libitum and abstinent smokers. Pharmacol Biochem Behav 2003; 74:401-410
6. Roy MP, Steptoe A, Kirschbaum C. The association between smoking status and cardiovascular and cortisol stress responsivity in healthy young men. Int J Behav Med 1994;1:264-283
7. al'Absi M, Hatsukami D, Davis GL. Attenuated adrenocorticotropic responses to psychological stress are associated with early smoking relapse. Psychopharmacology (Berl) 2005;181:107-117
8. Martin del Campo AF, Dowson JH, Herbert J, Paykel ES. Effects of naloxone on diurnal rhythms in mood and endocrine function: a dose-response study in man. Psychopharmacology (Berl) 1994;114:583-590
9. Burnett FE, Scott LV, Weaver MG, Medbak SH, Dinan TG. The effect of naloxone on adrenocorticotropin and cortisol release: evidence for a reduced response in depression. J Affect Disord 1999;53:263-268
10. Schobel HP, Handwerker HO, Schmieder RE, Heusser K, Dominiak P, Luft FC. Effects of naloxone on hemodynamic and sympathetic nerve responses to pain in normotensive vs. borderline hypertensive men. J Auton Nerv Syst 1998;69:49-55.
11. McCubbin JA, Surwit RS, Williams RB, Nemeroff CB, McNeilly M. Altered pituitary hormone response to naloxone in hypertension development. Hypertens 1989;14:636-644
12. Schluger JH, Ho A, Borg L, Porter M, Maniar S, Gunduz M, Perret G, King A, Kreek MJ. Nalmefene causes greater hypothalamic-pituitary-adrenal axis activation than naloxone in normal volunteers: implications for the treatment of alcoholism. Alcohol Clin Exp Res 1998;22:1430-1436
13. Wand GS, Schumann H. Relationship between plasma adrenocortico-tropin, hypothalamic opioid tone, and plasma leptin. J Clin Endocrinol Metab 1998;83:2138-2142
14. Delitala G, Trainer PJ, Oliva O, Fanciulli G, Grossman AB. Opioid peptide and alpha-adrenoceptor pathways in the regulation of the pituitary-adrenal axis in man. J Endocrinol 1994;141:163-168
15. Krishnan-Sarin S, Rosen MI, O'Malley SS. Naloxone challenge in smokers. Preliminary evidence of an opioid component in nicotine dependence. Arch Gen Psychiatry 1999;56:663-668
16. Feine J, Bushnell M, Miron D. Sex differences in the perception of noxious heat stimuli. Pain 1991;44:255-262
17. Jensen R, Rasmussen B, Pedersen B. Cephalic muscle tenderness and pressure pain threshold in a general population. Pain 1992;48:197-203.
18. Fillingim R, Maixner W. The influence of resting blood pressure and gender on pain responses. Psychosom Med 1996;58:326-332
19. al'Absi M, Buchanan TW, Marrero A, Lovallo WR. Sex differences in pain perception and cardiovascular responses in persons with parental history for hypertension. Pain 1999;83:331-338
20. Zatzic DF, Dimsdale JE. Cultural variations in response to painful stimuli. Psychosom Med 1990;52:544-557
21. al'Absi M, Petersen KL, Wittmers LE. Adrenocortical and hemodynamic predictors of pain perception in men and women. Pain 2002;96:197-204.
22. Girdler SS, Maixner W, Naftel HA, Stewart PW, Moretz RL, Light KC. Cigarette smoking, stress-induced analgesia and pain perception in men and women. Pain 2005;114:372-385
23. Wolff BB. Methods of testing pain mechanisms in normal man. In: Wall PD, Melzack R, editors. Textbook of Pain. New York: Churchill Livingstone; 1984.
24. Posner J, Telekes A, Crowley D, Phillipson R, Peck AW. Effects of an opiate on cold-induced pain and the CNS in healthy volunteers. Pain 1985;23:73-82. (Pubitemid 15236654)
25. Chen AC, Dworkin SF, Haug J, Gehrig J. Human pain responsivity in a tonic pain model: psychological determinants. Pain 1989;37:143-160
26. Melzack R. The short-form McGill pain questionnaire. Pain 1987;30: 191-197
27. Fillingim RB, Maixner W, Bunting S, Silva S. Resting blood pressure and thermal pain responses among females: effects on pain unpleasantness but not pain intensity. Int J Psychophysiol 1998;30:313-318
28. Dressendorfer RA, Kirschbaum C, Rohde W, Stahl F, Strasburger CJ. Synthesis of a cortisol-biotin conjugate and evaluation as a tracer in an immunoassay for salivary cortisol measurement. J Steroid Biochem Mol Biol 1992;43:683-692
29. al'Absi M, Lovallo WR, McKey B, Sung BH, Whitsett TL, Wilson MF. Hypothalamic-pituitary-adrenocortical responses to psychological stress and caffeine in men at high and low risk for hypertension. Psychosom Med 1998;60:521-527
30. al'Absi M, Lovallo WR, McKey B, Pincomb G. Borderline hypertensives produce exaggerated adrenocortical responses to mental stress. Psycho-som Med 1994;56:245-250
31. Lundberg U, Frankenhaeuser M. Pituitary-adrenal and sympathetic-adrenal correlates of distress and effort. J Psychosom Res 1980;24:125-130
32. King AC, Meyer PJ. Naltrexone alteration of acute smoking response in nicotine-dependent subjects. Pharmacol Biochem Behav 2000;66:563-572
33. Heatherton TF, Kozlowski LT, Frecker RC, Fagerstrom KO. The Fager-strom test for nicotine dependence: a revision of the Fagerstrom tolerance questionnaire. Br J Addict 1991;86:1119-1127
34. Spielberger CD, Gorsuch R, Lushene R. State-Trait Anxiety Manual. Palo Alto, CA: Consulting Psychological Press; 1983.
35. Cohen S, Kamarck T, Mermelstein R. A global measure of perceived stress. J Health Soc Behav 1983;24:385-396
36. Vasey MA, Thayer JF. The continuing problem of false positives in repeated measures ANOVA in psychophysiology: a multivariate solution. Psychophysiology 1987;24:479-486
37. Jennings JR. Editorial policy on analyses of variance with repeated measures. Psychophysiology 1987;24:474-475
38. Gilbert DG, Meliska CJ, Plath LC. Noise stress does not modulate effects of smoking/nicotine on /3-endorphin, cortisol, ACTH, glucose, and mood. Psychopharmacology 1997;130:197-202.
39. Ussher M, West R, Evans P, Steptoe A, McEwen A, Clow A, Huck-lebridge F. Reduction in cortisol after smoking cessation among users of nicotine patches. Psychosom Med 2006;68:299-306.
40. Kirschbaum C, Hallhammer D. Methodological aspects of salivary cortisol measurement. In: Kirschbaum C, Read GF, Hellhammer DH, editors. Assessment of Hormones and Drug in Saliva in Biobehavioral Research. Seattle: Hogrefe & Huber; 1992.
41. Kudielka BM, Buske-Kirschbaum A, Hellhammer DH, Kirschbaum C. HPA axis responses to laboratory psychosocial stress in healthy elderly adults, younger adults, and children: impact of age and gender. Psycho-neuroendocrinology 2004;29:83-98. (Pubitemid 37303960)
42. Dhillo WS, Kong WM, Le Roux CW, Alaghband-Zadeh J, Jones J, Carter G, Mendoza N, Meeran K, O'Shea D. Cortisol-binding globulin is important in the interpretation of dynamic tests of the hypothalamic-pituitary-adrenal axis. Eur J Endocrinol 2002;146:231-235
43. Bujdoso E, Jaszberenyi M, Tomboly C, Toth G, Telegdy G. Effects of endomorphin-1 on open-field behavior and on the hypothalamic-pituitary-adrenal system. Endocrine 2001;14:221-224
44. Valentino RJ, Van Bockstaele E. Opposing regulation of the locus coer-uleus by corticotropin-releasing factor and opioids. Potential for reciprocal interactions between stress and opioid sensitivity. Psychopharmacology (Berl) 2001;158:331-342
45. Cunningham ETJ, Bohn MC, Sawchenko PE. Organization of adrenergic inputs to the paraventricular and supraoptic nuclei of the hypothalamus in the rat. J Comp Neurol 1990;292:651-667
46. Chrousos GP, Gold PW. The concepts of stress and stress system disorders. Overview of physical and behavioral homeostasis. JAMA 1992; 267:1244-1252
47. Wewers ME, Dhatt RK, Snively TA, Tejwani GA. The effect of chronic administration of nicotine on antinociception, opioid receptor binding and met-enkelphalin levels in rats. Brain Res 1999;822:107-113
48. Aceto MD, Scates SM, Ji Z, Bowman ER. Nicotine's opioid and anti-opioid interactions: proposed role in smoking behavior. Eur J Pharmacol 1993;248:333-335
49. Pomerleau O. Endogenous opioids and Smoking: a review of progress and problems. Psychoneuroendocrinology1998;23:115-130
50. Seyler Jr. LE, Fertig J, Pomerleau O, Hunt D, Parker K. The effects of smoking on ACTH and cortisol secretion. Life Sci 1984;34:57-65.
51. Lutfy K, Brown MC, Nerio N, Aimiuwu O, Tran B, Anghel A, Friedman TC. Repeated stress alters the ability of nicotine to activate the hypotha-lamic-pituitary-adrenal axis. J Neurochem 2006;99:1321-1327
52. Baron JA, La Vecchia C, Levi F. The antiestrogenic effect of cigarette smoking in women. Am J Obstet Gynecol 1990;162:502-514
53. Frye CA, Bock BC, Kanarek RB. Hormonal milieu affects tailflick latency in female rats and may be attenuated by access to sucrose. Physiol Behav 1992;52:699-706.
54. Ratka A, Simpkins JW. Effects of estradiol and progesterone on the sensitivity to pain and on morphine-induced antinociception in female rats. Horm Behav 1991;25:217-228
55. Fillingim RB, Maixner W, Girdler SS, Light KC, Harris MB, Sheps DS, Mason GA. Ischemic but not thermal pain sensitivity varies across the menstrual cycle. Psychosom Med 1997;59:512-520
56. Wand GS, McCaul M, Yang X, Reynolds J, Gotjen D, Lee S, Ali A. The mu-opioid receptor gene polymorphism (A118G) alters HPA axis activation induced by opioid receptor blockade. Neuropsychopharmacology 2002;26:106-114
57. Chong RY, Oswald L, Yang X, Uhart M, Lin PI, Wand GS. The Micro-opioid receptor polymorphism A118G predicts cortisol responses to naloxone and stress. Neuropsychopharmacology 2006;31:204-211